DR. NURHAFIZA BINTI ZAINAL
Department of Medical Microbiology
Faculty of Medicine
nurhafizazainalum.edu.myView CV | |
View 1-Page CV | |
Publons | |
Scopus Link | |
Biography | |
Dr. Nurhafiza Binti Zainal is a Senior Lecturer at the Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya. She holds a Dual PhD in Medical Microbiology from Universiti Malaya and Medicine from National Cheng Kung University, Taiwan. Additionally, she earned an MRes in Biotechnology from Imperial College London, United Kingdom, and a bachelor’s degree in Biotechnology from Universiti Malaya. Her areas of expertise include immunology and virology. Dr. Nurhafiza’s research explores the intricate relationship between viruses and the host immune response, particularly the role of host protein expression and genetic factors in shaping disease outcomes. Her work also investigates mechanisms such as cross-reactive immunity and antibody-dependent enhancement to improve vaccine development and antiviral strategies. She has served as both Principal Investigator and Co-Researcher on numerous national-level research grants, including projects under the Ministry of Higher Education (MOHE), MOSTI, and Universiti Malaya internal funding schemes. Dr. Nurhafiza is also the recipient of the prestigious IEIF International Education Innovation Fund – ASEAN Research Collaboration Project, hosted by The University of Adelaide. Her awarded project focuses on the development and evaluation of inactivated vaccines for viral diseases, with potential applications in animal health. In addition to her scientific research, Dr. Nurhafiza is involved in interdisciplinary initiatives such as One Health programs and sustainability-focused projects related to menstrual health and environmental responsibility |
Publication
Finance
Project Title | Progress | Status |
---|---|---|
Enhancing The Safety And Efficacy Of Vaccines: Investigating Cross-reactive Immunity And Antibody-dependent Enhancement (ade) For Improved Vaccine Development |
|
on going |
CD5L: A Novel Key Protein In Dengue Virus Infection |
|
on going |
Susceptibility Of Recovered Covid-19 Patients And Covid-19 Vaccinated Individuals To Severe Manifestation Of Covid-19: Genetic Predisposition, Cross-reactive Immunity, And Antibody-dependent Enhancement (long Term Outcomes And Genetics: Longtong) |
|
end |
This information is generated from Research Grant Management System |
Asian households' dengue-related knowledge, attitudes, and practices: a systematic review
Antimicrobial properties of <i>Sonchus</i> species: A review
Antiviral immune responses in human reproductive tract: Pathogenic mechanisms and therapeutic implications
Association of total and dengue-specific IgE levels in the sera with dengue virus inhibition and antibody-dependent enhancement